By leveraging biomarker interpretation and education, healthcare providers can make significant strides towards improving cancer outcomes and combating this global health challenge effectively.... Apr 15
For every standard deviation increase in accelerated ageing, there was a corresponding 42% higher risk of early-onset lung cancer, a 22% higher risk of ... Apr 10
The study sheds light on potential biomarkers for food allergies in infants, presenting a promising avenue for preventive measures.... Apr 02
Hydration is important for all ages, and a population survey finds that about 50% of people do not drink recommended amounts. A new study has ... Jan 09
Once considered a disease of older patients, heart diseases are now prominent in young generations too. Now 1 in 5 heart attack patients is younger ... Oct 18
Latest Pharma news... Feb 23
Nutrition startup Elo Health has raised $5 million from former NFL player and from the co-founder of Oura ring. ... Feb 11
Digital biomarker startup Koneksa has raised $45 million in their Series C funding round.... Feb 08
Latest pharma news updates... Nov 12
Latest pharma update... Sep 27
Latest Pharma News Update... Sep 03
OncoStem develops innovative prognostic tests for assessing aggressiveness of tumours in the breast. The test is known as CanAssist Breast Test. It helps in identifying ... Jul 20
Now there would be an easy way to test for Parkinson's disease in elderly... Mar 13
The product candidate has received multiple IND approvals from both the US FDA and Chinese NMPA... Jan 18
LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer.... Dec 28
ASC42 received Fast Track designation from the US FDA for NASH... Dec 28
The primary endpoint of this trial was to evaluate patients for complete histological clearance of the tumour cells within the treated isSCC lesion... Dec 21
... Dec 08
CPI-818, an oral interleukin-2-inducible T-cell kinase inhibitor, is well-tolerated and active in patients with T-cell lymphoma... Dec 07
PureTech’s global, randomized, double-blind, placebo-controlled Phase 2 trial is designed to evaluate the efficacy, safety and tolerability of LYT-100 in adults ... Dec 05
The deep learning model is able to translate the full diversity of subtle imaging biomarkers in the mammogram that can predict a woman's future ... Nov 30
Latest FDA News Nov 26, 2020... Nov 26
Senhwa announces multiple IND application submissions to US FDA and Health Canada evaluating its investigational drug, CX-5461, for the treatment of patients with solid ... Nov 26
ARCA believes that AB201 is the only anticoagulant class new chemical entity in development for COVID-19 that has a Fast Track designation... Nov 24
... Nov 12
-Advertisements-